申请人:Terumo Kabushiki Kaisha
公开号:US04619938A1
公开(公告)日:1986-10-28
Alkanolamine derivatives and platelet aggregation inhibitors containing the same as an active ingredient are disclosed. The alkanolamine derivatives are novel compounds which possess potent platelet aggregation inhibitory activities and effective in preventing diseases such as thrombosis. As typical compounds are mentioned N-5,8,11,14,17-eicosapentaenoyl-2-aminoethanol, N-nicotinoyl-2-aminoethyl-5,8,11,14,17-eicosapentaenoate, N-ethyl-N-5,8,11,14,17-eicosapentaenoyl-2-aminoethanol, N-butyl-N-5,8,11,14,17-eicosapentaenoyl-2-aminoethanol, N-5,8,11,14,17-3-aminopropylnicotinate, (N-ethyl-N-nicotinoyl-2-aminoethyl)-5,8,11,14,17-eicosapentaenoate and the like.
揭示了含有Alkanolamine衍生物和血小板聚集抑制剂的作为活性成分的化合物。这些Alkanolamine衍生物是新颖的化合物,具有强大的血小板聚集抑制活性,并且有效预防血栓等疾病。典型的化合物包括N-5,8,11,14,17-二十碳五烯酰基-2-氨基乙醇,N-烟酰基-2-氨基乙基-5,8,11,14,17-二十碳五烯酸酯,N-乙基-N-5,8,11,14,17-二十碳五烯酰基-2-氨基乙醇,N-丁基-N-5,8,11,14,17-二十碳五烯酰基-2-氨基乙醇,N-5,8,11,14,17-3-氨基丙基烟酸酯,(N-乙基-N-烟酰基-2-氨基乙基)-5,8,11,14,17-二十碳五烯酸酯等。